[go: up one dir, main page]

DE69229004D1 - Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung - Google Patents

Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung

Info

Publication number
DE69229004D1
DE69229004D1 DE69229004T DE69229004T DE69229004D1 DE 69229004 D1 DE69229004 D1 DE 69229004D1 DE 69229004 T DE69229004 T DE 69229004T DE 69229004 T DE69229004 T DE 69229004T DE 69229004 D1 DE69229004 D1 DE 69229004D1
Authority
DE
Germany
Prior art keywords
rgd
compositions
methods
adhesion formation
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229004T
Other languages
English (en)
Inventor
Gere Dizerega
Kathleen Rodgers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Application granted granted Critical
Publication of DE69229004D1 publication Critical patent/DE69229004D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69229004T 1991-11-07 1992-11-06 Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung Expired - Lifetime DE69229004D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78923191A 1991-11-07 1991-11-07
PCT/US1992/009494 WO1993008818A1 (en) 1991-11-07 1992-11-06 Compositions and methods for preventing adhesion formation

Publications (1)

Publication Number Publication Date
DE69229004D1 true DE69229004D1 (de) 1999-05-27

Family

ID=25146991

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229004T Expired - Lifetime DE69229004D1 (de) 1991-11-07 1992-11-06 Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung

Country Status (8)

Country Link
US (1) US5629294A (de)
EP (1) EP0667783B1 (de)
AT (1) ATE179074T1 (de)
AU (1) AU3064892A (de)
DE (1) DE69229004D1 (de)
TW (1) TW269634B (de)
WO (1) WO1993008818A1 (de)
ZA (1) ZA928607B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DE19529909C2 (de) * 1995-08-15 1998-04-09 Fresenius Ag Wässrige Spüllösung
EP0793965A3 (de) * 1996-02-29 1999-02-24 Tano, Yasuo Prophylaktische/therapeutische Zusammensetzung für Nachstar
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
EP1100558A1 (de) * 1998-07-24 2001-05-23 Pharmacal Biotechnologies, Inc. Methode und verfahren zur rekonstruktion von knochengewebe
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
WO2000072856A1 (en) * 1999-06-01 2000-12-07 Bristol-Myers Squibb Company Fibrin sealants providing less inflammatory response and methods using same
US20010053766A1 (en) * 2000-02-11 2001-12-20 Janardan Kumar Method of treating disorders of the eye
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
WO2005053683A1 (en) * 2003-11-26 2005-06-16 Duke University A method of preventing or treating glaucoma
WO2006078282A2 (en) 2004-04-28 2006-07-27 Angiotech Biomaterials Corporation Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
CN101379082A (zh) 2006-01-19 2009-03-04 爱吉恩公司 治疗血管相关疾病的包含肽的药物组合物
WO2007083949A1 (en) * 2006-01-19 2007-07-26 Eyegene Inc. Pharmaceutical composition for treating vascular-related diseases comprising peptide
US9101581B2 (en) 2008-10-27 2015-08-11 Eyegene Inc. Method for treating vascular-related disease
AU2008297906A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptide Phpfhlfvy (Renin inhibitor) as a therapeutic agent
AU2008297935A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a RGD-peptide and/or parathyroid hormone (1-34 ) as anti-HIV agent
CA2698974A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
RU2010113977A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение антагониста рецептора фибриногена и/или пептид фолликулярного гонадолиберина в качестве терапевтического средства при лечении инфекции streptococcus pneumoniae
US20110250284A1 (en) * 2008-06-24 2011-10-13 Lavik Erin B Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
US9555071B2 (en) * 2012-06-13 2017-01-31 Thien Nguyen Methods and compositions for the treatment of axonal and neuronal degeneration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
DE3781263T2 (de) * 1986-12-15 1993-04-08 Inst Nat Sante Rech Med Peptid-derivate und deren verwendung in der therapie.
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
JPH02240020A (ja) * 1989-01-26 1990-09-25 Childrens Medical Center Corp:The 外科的切除後の腫瘍再発阻止剤
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
US5169833A (en) * 1989-12-15 1992-12-08 G. D. Searle & Co. Substituted cyclic pentapeptides

Also Published As

Publication number Publication date
EP0667783B1 (de) 1999-04-21
US5629294A (en) 1997-05-13
EP0667783A1 (de) 1995-08-23
AU3064892A (en) 1993-06-07
ATE179074T1 (de) 1999-05-15
EP0667783A4 (de) 1995-04-25
WO1993008818A1 (en) 1993-05-13
ZA928607B (en) 1993-06-07
TW269634B (de) 1996-02-01

Similar Documents

Publication Publication Date Title
ATE179074T1 (de) Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
AR041913A1 (es) Formulaciones de deposito de liberacion controlada
DE69705746D1 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
CA2186126A1 (en) Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
ATE261278T1 (de) Mikrokapseln zum verabreichen von neuroaktiven wirkstoffen
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
ATE122879T1 (de) Verabreichungsformen für pharmaka.
RU2004111596A (ru) Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
DE69323195D1 (de) VERKÜRZTER GEWEBSFAKTOR UND FVIIa ODER FVII ZUR AKTIVIERUNG DER BLUTGERINNUNG
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
ATE141790T1 (de) Medikament zur hemmung der stickoxid-bildung
IE61346B1 (en) A permeable material to fit around the teeth or gums of a mammal
ATE171869T1 (de) Film zur lokalen arzneistoffabgabe für periodontale behandlung
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
DE69808938D1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
Cullum et al. Evaluation of hydroxylapatite particles in repair of alveolar clefts in dogs
FR2686250B1 (de)
ATE289506T1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
BR9804768A (pt) Droga e aplicação de uma mistura
Carroll et al. The histologic effect of topically applied acetylsalicylic acid on bone healing in rats
Nawata et al. Bone Regeneration in Femoral Defect Filled with Fibrin Sealant. An Experimental Study

Legal Events

Date Code Title Description
8332 No legal effect for de